about
The periodontal health of homosexual men with HIV infection: a controlled study.Glycoform composition profiling of O-glycopeptides derived from human serum IgA1 by matrix-assisted laser desorption ionization-time of flight-mass spectrometry.Human serum IgA1 is substituted with up to six O-glycans as shown by matrix assisted laser desorption ionisation time-of-flight mass spectrometry.Review article: cinnamon- and benzoate-free diet as a primary treatment for orofacial granulomatosis.Cytokine and adhesion molecule expression in the minor salivary glands of patients with Sjögren's syndrome and chronic sialoadenitis.An early view of the international Sjögren's syndrome registry.Oral and vaginal epithelial cell lines bind and transfer cell-free infectious HIV-1 to permissive cells but are not productively infected.Paraneoplastic cicatricial pemphigoid.Recognizing and caring for the medically compromised child: 3. Disorders affecting the gastro-intestinal tract and human immunodeficiency virus infection.A novel human IgA monoclonal antibody protects against tuberculosis.In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasisOral candidosis.American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohortA biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells.Management of recurrent oral herpes simplex infections.Saliva and inhibition of HIV-1 infection: molecular mechanisms.Oral mucosal immunity and HIV infection: current status.Oral health and disease in AIDS. IntroductionCandida albicans secreted aspartyl proteinases in virulence and pathogenesisMurine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions.Candida albicans HWP1 gene expression and host antibody responses in colonization and disease.Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS.Systemic tolerance and secretory immunity after oral immunization.The effects of HIV infection on oral mucosal immunity.The vulvovaginal gingival syndrome: a severe subgroup of lichen planus with characteristic clinical features and a novel association with the class II HLA DQB1*0201 allele.Use of prophylactic antifungals in the immunocompromised host.The effects of surface machining on heat cured acrylic resin and two soft denture base materials: a scanning electron microscope and confocal microscope evaluation.Genetic Association Analysis Reveals Differences in the Contribution of NOD2 Variants to the Clinical Phenotypes of Orofacial Granulomatosis.Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel disease.Experience with anti-TNF-α therapy for orofacial granulomatosis.Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review.Development of a low phenolic acid diet for the management of orofacial granulomatosis.Fifteen-minute consultation: a structured approach to the management of recurrent oral ulceration in a child.Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.Biodegradable microparticles for oral immunization.Epithelioid Haemangioendothelioma of the mandibular gingiva: case report and literature review.Azathioprine is effective for oral involvement in Crohn's disease but not for orofacial granulomatosis alone.Genome-Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to Ancestry.The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome.Prevalence of legionella waterline contamination and Legionella pneumophila antibodies in general dental practitioners in London and rural Northern Ireland.
P50
Q30492382-E75B5C77-9892-439D-B2BC-06C0B895C82CQ30832695-BEA7ADD0-91B3-4475-9D95-97CE6E194849Q30838963-03FD9653-340D-4373-BBA1-400DD3F84661Q31029235-E290801B-78E7-4DA9-959C-118AEA3D057BQ33567121-D8A2CBD4-D2A1-4DDF-B257-6AC3A9ACB15BQ33642772-220D1BB3-8AC2-477A-BD51-34E9CA045A67Q33654841-88022E8E-F9E7-4C78-8EBF-98F05C4C5F9FQ33693971-52EB6544-A942-45B3-A8E8-45FE944243A2Q33729101-452192BB-FAD0-4E4B-ABBB-900347E80672Q33800841-3FF85406-4621-4AEC-8F17-AF9C445B14E5Q33867435-73E148D3-432D-4E17-91AC-F7C6EBD5B177Q34116655-A114F0B8-1ADA-498B-97E9-F5D2895AA595Q34260251-4EE4A26B-7C3F-4FAB-9777-78C465F16BBCQ34346630-73A2336A-451A-40AE-BFF4-F95EA1D586F9Q34578009-6FF249EA-F4CF-40F4-A5AA-3BE665F1A23DQ34775243-897B9058-FA07-4EE5-890B-3D1E670DBBDCQ34775263-35C54989-6B84-423B-A54D-4C27C4CFBA4EQ35129068-6756A68E-97CC-408E-85B1-FC9A7E0BA3A8Q35215948-83E9374A-F383-4AEF-AB08-5FC8D0F3A679Q35624490-43A7047F-54D4-4AE2-A3AD-150FB15409D6Q35629656-05D18630-E823-45F5-B90D-D0C8CF354E18Q35774918-16549CB1-8DCF-4233-B277-3B202FC620D9Q36344216-9AAA3B77-1901-46BF-9CC7-8118F5FABA9BQ36467653-C34AF9E4-6CE1-4881-A8E1-D84147648D17Q36509696-E21A7521-43BB-4FC4-9899-1644A679FC05Q36767158-F47EE4E1-667E-48CA-A31C-3DB1A73BE7A8Q36876776-EAEFD98C-EC8E-4F6B-8A8B-44D7DEE2A608Q37016579-60E0E88D-C19A-44B4-8CAF-3E8EBCFEA688Q37116082-FCCC4FCC-A8E6-428E-A478-9ED5910C764AQ37830406-6A767D16-FD8C-4D3C-A174-966D34461381Q37850481-D054AC18-825D-406A-8A9F-48A7FAF8637CQ38097924-34831D9D-32D9-4481-9972-AD0E203D35DAQ38139913-9AABBC7E-2DFA-4A4A-BB4E-084EF70A0D7CQ38559038-F127DE7D-A62E-45FA-B235-7BCD6C5BCF7FQ38565970-1F55AAB2-3BC2-4C35-BBD2-24623568CF91Q38571733-FBF7D340-BA28-4909-B6EA-77BD7BFB362CQ38643064-5326B01B-13E7-42C7-9AF4-4F6D59B4C811Q39026679-59405EBA-477F-4EBF-B98E-2EC9B4DA8611Q39033400-5FB335C3-D387-4A7A-A1EC-CC7D34ED2E3CQ39669792-DFCCF89C-AE27-41AC-9570-4F8B7B9D7808
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stephen Challacombe
@ast
Stephen Challacombe
@en
Stephen Challacombe
@es
Stephen Challacombe
@nl
type
label
Stephen Challacombe
@ast
Stephen Challacombe
@en
Stephen Challacombe
@es
Stephen Challacombe
@nl
prefLabel
Stephen Challacombe
@ast
Stephen Challacombe
@en
Stephen Challacombe
@es
Stephen Challacombe
@nl
P214
P106
P108
P1153
7006005250
P214
P31
P496
0000-0002-7327-6927
P7859
viaf-315231244